Sunesis Pharmaceuticals
| Region | Nordamerika |
| ISIN | US8673288747 |
| Sektor | Biotechnologie |
| Website | https://www.sunesis.com/ |
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.
| Titel | Autor | Datum |
|---|---|---|
|
Risikoarmes "Peak Play" mit Multibagger-Potenzial
|
sharedeals | translation missing: de.datetime.time_ago_in_words.almost_x_years |
| Titel | Datum |
|---|---|
| RHB Research: MISC's prospects remain solid with continuing growth in global oil demand | vor ungefähr einem Monat |
| MISC, S P Setia, Gas Malaysia, Mega First, Dayang Enterprise, Sunway REIT, Magnum, Dialog, Kobay, AME Elite Consortium, Lambo | vor ungefähr einem Monat |
| MISC books 2Q net loss of RM19m, pays seven sen dividend | vor ungefähr einem Monat |
| MISC slips into RM19m 2Q net loss from RM539m net profit a year earlier | vor ungefähr einem Monat |
| MARC Affirms AAA Ratings On MISC's RM2.5 Billion Islamic MTN | vor ungefähr einem Monat |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Suedzucker (1 Artikel) | |
| Stockholm IT Ventures AB (1 Artikel) | |
| Tahoe Resources (1 Artikel) | |
| Telit Communications (3 Artikel) | |
| Alle anzeigen | |